Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|August 23, 2024
Patient Selection Is the Key for Successful Video Appointments: Lessons Learned from the COVID-19 PandemicIlkka Rauma, Marja Niiranen, Hanna Kuusisto
Studies in Health Technology and Informatics|October 23, 2023
Neurologists' Experiences and Attitudes Towards Teleneurology - Has Covid-19 Pandemic Made a Difference?Tapio Rautell, Marja Niiranen, Hanna Kuusisto
Multiple Sclerosis and Related Disorders|July 13, 2023
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMSHenrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Multiple Sclerosis and Related Disorders|September 13, 2025
The real-world efficacy of Cladribine tablets and treatment persistence in people with highly active relapsing multiple sclerosis in Finland - A follow-up study after four years of observationIlkka Rauma, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis and Related Disorders|December 22, 2019
Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessationTiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
JMIR Human Factors|August 22, 2025
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational StudyPäivi Hämäläinen, Elina Lämsä, Matias Viitala, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2025
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registryPäivi Hämäläinen, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 6, 2025
Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis-A nationwide population-based studyMaiju Savolainen, Matias Viitala, Katariina Kuutti, et al.
Multiple Sclerosis and Related Disorders|October 9, 2021
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosisMarja Niiranen, Aleksi Kontkanen, Olli Jääskeläinen, et al.
Pageof 2